![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
F Oury-Donat, P Carayon, O Thurneyssen, V Pailhon, X Emonds-Alt, P Soubrie and G Le Fur
Sanofi Recherche, Department of Neuropsychiatry, Montpellier, France.
The effects of SR142801, a nonpeptide tachykinin neurokinin (NK3) receptor antagonist, were investigated on the functional events linked to NK3 receptor activation by using Chinese hamster ovary (CHO) cells transfected with the human NK3 receptor. Radioligand binding conducted with [125I]iodohistidyl-[MePhe7]-NKB revealed a competitive inhibition by SR142801 and its (-)-antipode SR142806 with Ki values of 0.21 +/- 0.03 and 32.0 +/- 5.0 nM, respectively. NK3 agonists such as [MePhe7]- NKB and senktide stimulated inositol monophosphate formation with EC50 values of 2.0 +/- 1.4 and 2.1 +/- 0.7 nM, respectively. SR142801 antagonized the stimulatory effect of [MePhe7]-NKB (10(-8) M) with an IC50 of 14.3 +/- 2.6 nM and of senktide (10(-8) M) with an IC50 of 4.8 +/- 1.5 nM. The [3H]arachidonic acid release induced by either [MePhe7]- NKB (EC50 of 2.6 +/- 0.2 nM) or senktide (EC50 of 4.2 +/- 2.9 nM) also was inhibited by SR142801 with IC50 values of 16.1 +/- 0.5 and 8.0 +/- 1.7 nM, respectively. The cyclic AMP accumulation induced by 10(-7) M [MePhe7]-NKB (EC50 of 54 +/- 2 nM) also was antagonized by SR142801 with an IC50 value of 4.0 +/- 0.7 nM. These antagonistic effects were stereospecific and NK3 receptor specific because the (-)-antipode, SR142806, was much less effective than SR142801 in NK3 agonist-evoked responses, whereas the nonpeptide NK1 (SR140333) and NK2 (SR48968) receptor antagonists were almost inactive. The activity of SR142801 also was evaluated on the [Ca++]i increase induced by 10(-9) M [MePhe7]- NKB.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
 |
|
  P. Malherbe, C. Bissantz, A. Marcuz, C. Kratzeisen, M.-T. Zenner, J. G. Wettstein, H. Ratni, C. Riemer, and W. Spooren Me-Talnetant and Osanetant Interact within Overlapping but Not Identical Binding Pockets in the Human Tachykinin Neurokinin 3 Receptor Transmembrane Domains Mol. Pharmacol., June 1, 2008; 73(6): 1736 - 1750. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Andre, N. Cherouati, C. Prual, T. Steffan, G. Zeder-Lutz, T. Magnin, F. Pattus, H. Michel, R. Wagner, and C. Reinhart Enhancing functional production of G protein-coupled receptors in Pichia pastoris to levels required for structural studies via a single expression screen Protein Sci., May 1, 2006; 15(5): 1115 - 1126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Y. Meltzer, L. Arvanitis, D. Bauer, W. Rein, and Meta-Trial Study Group Placebo-Controlled Evaluation of Four Novel Compounds for the Treatment of Schizophrenia and Schizoaffective Disorder Am J Psychiatry, June 1, 2004; 161(6): 975 - 984. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. M. Page, N. J. Bell, S. M. Gardiner, I. T. Manyonda, K. J. Brayley, P. G. Strange, and P. J. Lowry Characterization of the endokinins: Human tachykinins with cardiovascular activity PNAS, May 13, 2003; 100(10): 6245 - 6250. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-Y. Chen, A. C. Bonham, C. G. Plopper, and J. P. Joad Plasticity in Respiratory Motor Control: Selected Contribution: Neuroplasticity in nucleus tractus solitarius neurons after episodic ozone exposure in infant primates J Appl Physiol, February 1, 2003; 94(2): 819 - 827. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Emonds-Alt, V. Proietto, R. Steinberg, F. Oury-Donat, X. Vige, P. Vilain, E. Naline, S. Daoui, C. Advenier, G. Le Fur, et al. SSR240600 [(R)-2-(1-{2-[4-{2-[3,5-Bis(trifluoromethyl)phenyl]acetyl}-2-(3,4-dichlorophenyl)-2-morpholinyl]ethyl}- 4-piperidinyl)-2-methylpropanamide], a Centrally Active Nonpeptide Antagonist of the Tachykinin Neurokinin-1 Receptor: I. Biochemical and Pharmacological Characterization J. Pharmacol. Exp. Ther., December 1, 2002; 303(3): 1171 - 1179. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. W. P. Hay, G. A. M. Giardina, D. E. Griswold, D. C. Underwood, C. J. Kotzer, B. Bush, W. Potts, P. Sandhu, D. Lundberg, J. J. Foley, et al. Nonpeptide Tachykinin Receptor Antagonists. III. SB 235375, a Low Central Nervous System-Penetrant, Potent and Selective Neurokinin-3 Receptor Antagonist, Inhibits Citric Acid-Induced Cough and Airways Hyper-reactivity in Guinea Pigs J. Pharmacol. Exp. Ther., January 1, 2002; 300(1): 314 - 323. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. M. Sarau, D. E. Griswold, B. Bush, W. Potts, P. Sandhu, D. Lundberg, J. J. Foley, D. B. Schmidt, E. F. Webb, L. D. Martin, et al. Nonpeptide Tachykinin Receptor Antagonists. II. Pharmacological and Pharmacokinetic Profile of SB-222200, a Central Nervous System Penetrant, Potent and Selective NK-3 Receptor Antagonist J. Pharmacol. Exp. Ther., October 1, 2000; 295(1): 373 - 381. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Grumann-Júnior, M. A. Dias, R. V. Alves, J. E. Boteon, and J. B. Calixto Mechanisms Mediating Substance P-Induced Contraction in the Rat Iris In Vitro Invest. Ophthalmol. Vis. Sci., June 1, 2000; 41(7): 1861 - 1870. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. P. Hamlin, M. J. Williams, A. J. Nimmo, and L. H. Crane Hormonal Variation of Rat Uterine Contractile Responsiveness to Selective Neurokinin Receptor Agonists Biol Reprod, June 1, 2000; 62(6): 1661 - 1666. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. DAOUI, C. COGNON, E. NALINE, X. EMONDS-ALT, and C. ADVENIER Involvement of Tachykinin NK3 Receptors in Citric Acid-induced Cough and Bronchial Responses in Guinea Pigs Am. J. Respir. Crit. Care Med., July 1, 1998; 158(1): 42 - 48. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Weinreich, K. A. Moore, and G. E. Taylor Allergic Inflammation in Isolated Vagal Sensory Ganglia Unmasks Silent NK-2 Tachykinin Receptors J. Neurosci., October 15, 1997; 17(20): 7683 - 7693. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. M. Sarau, D. E. Griswold, W. Potts, J. J. Foley, D. B. Schmidt, E. F. Webb, L. D. Martin, M. E. Brawner, N. A. Elshourbagy, A. D. Medhurst, et al. J. Pharmacol. Exp. Ther., June 1, 1997; 281(3): 1303 - 1311. [Abstract] [Full Text]
|
|
|
|
|
|
J. E. Krause, P. T. Staveteig, J. N. Mentzer, S. K. Schmidt, J. B. Tucker, R. M. Brodbeck, J.-Y. Bu, and V. V. Karpitskiy Functional expression of a novel human neurokinin-3 receptor homolog that binds [3H]senktide and [125I-MePhe7]neurokinin B, and is responsive to tachykinin peptide agonists PNAS, January 7, 1997; 94(1): 310 - 315. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Tian, L.-H. Wu, D. L. Oxender, and F.-Z. Chung The Unpredicted High Affinities of a Large Number of Naturally Occurring Tachykinins for Chimeric NK1/NK3 Receptors Suggest a Role for an Inhibitory Domain in Determining Receptor Specificity J. Biol. Chem., August 23, 1996; 271(34): 20250 - 20257. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
